Teladoc Health (NYSE: TDOC)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-10-26 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.640 | -0.440 | 0.2000 | ||||
REV | 583.760M | 592.379M | 8.619M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Teladoc Health (NYSE: TDOC) through any online brokerage.
Other companies in Teladoc Health’s space includes: Change Healthcare (NASDAQ:CHNG), MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX) and Pear Therapeutics (NASDAQ:PEAR).
The latest price target for Teladoc Health (NYSE: TDOC) was reported by Berenberg on Tuesday, August 2, 2022. The analyst firm set a price target for 35.00 expecting TDOC to fall to within 12 months (a possible -6.63% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Teladoc Health (NYSE: TDOC) is $37.485 last updated August 5, 2022, 7:59 PM UTC.
There are no upcoming dividends for Teladoc Health.
Teladoc Health’s Q3 earnings are confirmed for Wednesday, October 26, 2022.
There is no upcoming split for Teladoc Health.
Teladoc Health is in the Health Care sector and Health Care Technology industry. They are listed on the NYSE.